Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Focetria (H1N1 Vaccine) Dose-Finding Study in Children 3 to < 9 Years
NCT00972816Phase 3Completed
- Sponsor
- Novartis
- Start
- Sep 2009
- Primary completion
- Nov 2009
- Modality
- Split/Subunit Vaccines, Recombinant Protein Vaccines, Whole Inactivated Vaccines
- Countries
- 2
01
Overview
A Phase 3 trial of Influenza A virus A/California/7/2009 X-181 (H1N1) hemagglutinin antigen (propiolactone inactivated) in influenza, sponsored by Novartis. Started Sep 2009; status: completed.
02
Drugs
Influenza A virus A/California/7/2009 X-181 (H1N1) hemagglutinin antigen (propiolactone inactivated)
03
Conditions
influenza
Beyond the preview
Go deeper on NCT00972816.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00972816.